Plain-English translation of NCT07689214 on ClinicalTrials.gov ↗ ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a medication called Normast® 3 to see if it can help reduce the pain and nerve damage caused by diabetic polyneuropathy—a condition where diabetes damages nerves, especially in the feet and legs. You would take this medication for 12 weeks while continuing your regular diabetes care, and researchers would carefully measure whether it improves your nerve pain and how well your nerves are working.
Diabetic nerve pain is difficult to treat, and many patients don't get adequate relief from current treatments. This medication is being studied to see if it can help reduce pain and actually improve nerve function in people with this condition.
You likely qualify if…
You likely don't qualify if…
If you join this study, you would take either the new medication or a placebo tablet twice daily (after lunch and dinner) for 12 weeks, while keeping all your regular diabetes treatments the same. You would visit the study center at the beginning, after 12 weeks, and again at 24 weeks. During visits, researchers would perform various tests including nerve exams, skin biopsies (small tissue samples), sweat gland tests, heart function tests, and specialized sensory tests to measure how well your nerves are responding to treatment.
AI-generated summary from trial data · Jul 22, 2026 · Not medical advice
Italy